J G Kadar
Overview
Explore the profile of J G Kadar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kadar J, Schuster J, Hunzelmann N
Haemophilia
. 2007 Jan;
13(1):104-5.
PMID: 17212734
We report a 51-year-old patient with severe haemophilia A developing a severe life-threatening anaphylactic reaction to recombinant factor VIII (rFVIII). Anaphylactic reactions are a rare but well-known side effect of...
2.
Bauermann E, Shin M, Mohlmann M, Kadar J, Linde I
Anaesthesiol Reanim
. 1999 Oct;
24(4):101-8.
PMID: 10528416
High sub-pressure in high-vacuum suction bottles falls as the bottles fill up. Suction pumps with reservoir have a constant low suction level and decisive advantages. The question is: does the...
3.
Kadar J
Curr Opin Hematol
. 1998 Nov;
5(6):381-5.
PMID: 9814643
During the past 10 years, methods for blood component preparation have undergone considerable change. Refinements of traditional methodologies were necessary in response to demands for increasingly effective and safe platelet...
4.
Kadar J, Parusel M, Spaeth P
Transfus Sci
. 1998 Feb;
19 Suppl:9-23.
PMID: 10178699
The activation of the complement system leading to generation of anaphylatoxins and the membrane attack complex depends on the chemical nature of the adsorptive system and the anticoagulation used. The...
5.
Braun N, Kadar J, Risler T
Transfus Sci
. 1998 Feb;
19 Suppl:65-9.
PMID: 10178698
Extracorporeal immunoadsorption onto staphylococcal protein A replaces conventional plasmapheresis because its elimination efficiency is higher while less adverse reactions are seen. Experience in immunoadsorption is limited to specialized centers although...
6.
Serke S, Arseniev L, Watts M, Fritsch G, Johnsen H, Linch D, et al.
Bone Marrow Transplant
. 1997 Jul;
20(1):57-61.
PMID: 9232258
Determinations of committed haemopoietic progenitor cells, namely CFU-GM (colony-forming unit-granulocyte/macrophage) and of CD34-expression haemopoietic cells as assessed by multiparameter flow cytometry are routine diagnostic tools in haemopoietic cell therapy. Generally,...
7.
Chen D, Pastucha L, Chen H, Kadar J, Stangel W
Vox Sang
. 1997 Jan;
72(3):192-6.
PMID: 9145492
Objectives: Human platelet alloantigen (HPA) typing has potential clinical relevance in a variety of contexts. We can improve methods for HPA genotyping by complementing our knowledge of the DNA sequence...
8.
Technical and safety aspects of blood and marrow transplantation using G-CSF mobilized family donors
Kadar J, Arseniev L, Schnitger K, Sudmeier I, Zaki M, Battmer K, et al.
Transfus Sci
. 1996 Nov;
17(4):611-8.
PMID: 10168561
An allogeneic transplantation programme using immunoselected blood progenitor and bone marrow CD34+ cells has been established. Thirteen healthy HLA-matched, MLC negative sibling donors received two doses of 5 micrograms kg-1...
9.
Link H, Arseniev L, Bahre O, Kadar J, Diedrich H, Poliwoda H
Blood
. 1996 Jun;
87(11):4903-9.
PMID: 8639865
Pluripotent stem cells of hematopoiesis and lymphopoiesis are among the CD34+ cells in blood or bone marrow. After granulocyte-colony stimulating factor (G-CSF) treatment, 1% to 2% of the mononuclear cells...
10.
Arseniev L, Battmer K, Stucki A, Sudmeyer I, Kadar J, Martin M, et al.
Med Klin (Munich)
. 1996 Apr;
91 Suppl 3:50-9.
PMID: 8692120
Background: The clinical use of ex vivo expanded hematopoietic progenitor cells is currently explored. Material And Methods: In this study the culturing of G-CSF mobilized and purified CD34+ blood cells...